Radical prostatectomy (RP) is associated with improved survival in patients with prostate cancer and positive lymph nodes (LN), according to German researchers.
Jutta Engel, MD, of Ludwig-Maximilians-University, in Munich, and colleagues studied 1,413 patients with prostate cancer and positive lymph nodes diagnosed during pelvic LN dissection (PLND). Of these, 957 had a completed RP, and 456 had their RP abandoned. The median follow-up was 5.6 years.
The overall survival at five and 10 years was 84% and 64%, respectively, in the RP group and 60% and 28%, respectively, among in the abandoned RP group, the investigators reported in European Urology (2010; published online ahead of print).
Continue Reading
The relative survival at five and 10 years was 95% and 86%, respectively, for the RP group and 70% and 40%, respectively, for patients not treated with RP. In multivariate analysis, RP was associated with a twofold increased likelihood of survival.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.